๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Wuhan
Clinical trial register · China

Clinical Trials in Wuhan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology165 Tongji Hospital139 Huazhong University of Science and Technology45 Novartis Pharmaceuticals33 AbbVie31
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Wuhan

1343 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy
NCT07789483Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
DrugALXN2220
Alexion Pharmaceuticals, Inc.
Phase 3
1,180
Beijing, Chongqing, Guangzhou, Guiyang, Harbin, Wuhan, Changsha, Nanjing
2027-11-23
Not yet open
Clinical Study on the Safety and Efficacy of CD7-Targeted Chimeric Antigen Receptor (CAR) Gene-Modified T Cells for the Treatment of CD7-Positive Hematological Malignancies
NCT07345780CD7-Positive Hematological Malignancies
Donghua Zhang
Not applicable
28
Wuhan
2026-12-31
Not yet open
Efficacy of Mazdutide on Fatty Pancreas
NCT07803705Fatty Pancreas, Overweight, Obesity
DrugMazdutide
Tongji Hospital
Not applicable
194
Wuhan
2026-11-15
Not yet open
Mazdutide Plus LNG-IUS for Fertility-Sparing Treatment of AEH or Early Endometrial Cancer
NCT07781150Obesity, Overweight, Atypical Endometrial Hyperplasia, Endometrial Carcinoma Stage I
DrugMazdutide
Tongji Hospital
Phase 2
128
Zhengzhou, Wuhan, Changchun, Hangzhou, Shanghai, Tianjin
2026-11-01
Not yet open
A Multicenter, Randomized, Open-Label, Positive Controlled Phase III Study to Evaluate the Efficacy and Safety of VSA012 Injection in Participants With Paroxysmal Nocturnal Hemoglobinuria Who Are Naive to Complement Inhibitor Therapy
NCT07816237Paroxysmal Nocturnal Hemoglobinuria, PNH
DrugsSoliris·VSA012·Eculizumab
Bisirna Therapeutics (Suzhou) Co., Ltd.
Phase 3
70
Beijing, Jilin City, Quanzhou, Guangzhou, Nanning, Harbin, Zhengzhou, Wuhan
2026-10-29
Not yet open
A Clinical Study to Evaluate the Safety and Efficacy of GT802 Injection in the Treatment of Relapsing/Refractory Multiple Sclerosis
NCT07748637Multiple Sclerosis (MS)
Daishi Tian
Phase EARLY_PHASE1
12
Wuhan
2026-10-28
Recruiting
Iparomlimab and Tuvonralimab With Lenvatinib, Radiotherapy, and HAIC for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
NCT07776080HCC - Hepatocellular Carcinoma
DrugsIparomlimab and Tuvonralimab·Lenvatinib
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2
35
Wuhan
2026-10-01
Not yet open
Effect of Spontaneous Breathing in APRV Mode on Respiratory Physiology of ARDS Patients
NCT07798154Acute Respiratory Distress Syndrome
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
15
Wuhan
2026-10-01
Not yet open
AI-Guided First-Line Immunotherapy Selection in Unresectable Hepatocellular Carcinoma
NCT07729618Unresectable Hepatocellular Carcinoma
Tongji Hospital
Not applicable
1,800
Wuhan
2026-10-01
Not yet open
Radical Surgery Versus Non-Surgery in Gastric Cancer Patients With Peritoneal Metastasis After Successful Conversion Therapy
NCT07789184Gastric Cancer, Peritoneal Metastasis
Hua Huang, MD, PhD
Phase 3
170
Beijing, Chongqing, Zhangzhou, Guangzhou, Wuhan, Nanjing, Nantong, Nanchang
2026-10-01
Not yet open
FMT for Feeding Intolerance Due to Gastrointestinal Dysfunction in Critically Ill Patients
NCT07640633Feeding Intolerance, Gastrointestinal Dysfunction, Critically Ill Intensive Care Unit Patients
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
60
Wuhan
2026-10-01
Not yet open
AI-Guided Surveillance and Curative Salvage of Recurrence After Hepatocellular Carcinoma Resection or Ablation
NCT07732504Hepatocellular Carcinoma (HCC)
Tongji Hospital
Not applicable
2,000
Wuhan
2026-10-01
Not yet open
A Prospective, Multicenter,Single-arm Study of DuoCor 2 Ventricular Assist System for the Treatment of Advanced Biventricular Heart Failure
NCT07757451Advanced Heart Failure
Shenzhen Core Medical Technology CO.,LTD.
Not applicable
64
Wuhan
2026-10
Not yet open
A Phase 3 Study to Compare the Efficacy of ICP-248 in Combination With Orelabrutinib Versus Pirtobrutinib in Participants With Relapsed or Refractory Mantle Cell Lymphoma (r/r MCL).
NCT07784101Relapsed or Refractory Mantle Cell Lymphoma (MCL)
DrugsICP-248·Pirtobrutinib·Orelabrutinib
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 3
280
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Shijiazhuang, Zhengzhou, Wuhan
2026-10
Not yet open
Diagnostic Performance of ACP3-Targeted PET Imaging in Patients With Primary and Recurrent Prostate Cancer: An Open-Label, Single-Arm, Single-Center Study
NCT07830212Prostatic Neoplasms, Prostate Cancer
Drug[68Ga]Ga-OncoACP3
Yong He
Phase 2
50
Wuhan
2026-10
Not yet open
A Phase IV Clinical Trial of Influenza Vaccine (Split Virion), Inactivatedin (Anfluยฎ) Pregnant Women (AnFLU-PREG)
NCT07832201Influenza
Sinovac Biotech Co., Ltd
Phase 4
150
Changsha, Chengdu, Chongqing, Guangzhou, Nanjing, Wuhan
2026-10
Not yet open
Ciprofol, Propofol and Sevoflurane for Postoperative Delirium in Elderly Brain Tumor Patients
NCT07799623Brain Neoplasms, Delirium - Postoperative
DrugsCiprofol·Sevoflurane·Propofol
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
381
Wuhan
2026-09-30
Not yet open
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
NCT07816666Platinum-sensitive Relapsed Epithelial Ovarian Cancer, Platinum-sensitive Relapsed Fallopian Tube Cancer, Platinum-sensitive Relapsed Primary Peritoneal Cancer
DrugsTorvutatug samrotecan·Bevacizumab
AstraZeneca
Phase 3
600
Beijing, Guangdong Province, Guangzhou, Wuhan
2026-09-29
Not yet open
Neoadjuvant Therapy With Firmonertinib Combined With Anlotinib and Platinum-Based Doublet Chemotherapy for Resectable EGFR-Mutated NSCLC
NCT07807722NSCLC (Non-small Cell Lung Cancer), EGFR, Neoadjuvant Therapy
Hubei Cancer Hospital
Phase 2
29
Wuhan
2026-09-21
Not yet open
Phase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple Sclerosis
NCT07756268Multiple Sclerosis
DrugSYS6020
Tongji Hospital
Phase 1/2
25
Wuhan
2026-09-16
Not yet open
A Multicenter, Prospective, Randomized, Open-label Phase Ib/II Study of Celecoxib Plus Pembrolizumab and Gemcitabine/Cisplatin Versus Pembrolizumab and Gemcitabine/Cisplatin in Patients With CK5/6-High Unresectable Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma
NCT07632235Intrahepatic Cholangiocarcinoma (Icc)
DrugsGemcitabine/Cisplatin·Celecoxib·Pembrolizumab
Shanghai 6th People's Hospital
Phase 1/2
112
Guangzhou, Shanghai, Wuhan
2026-09-15
Recruiting
A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
NCT07811193Colorectal Adenocarcinoma
DrugsVVD-133214·Pembrolizumab
Vividion Therapeutics, Inc.
Phase 2
140
Bengbu, Beijing, Fuzhou, Guangzhou, Harbin, Wuhan, Jinan, Shanghai
2026-09-11
Not yet open
Individualized Drainage Strategy Based on Risk Stratification in Children Undergoing Surgery for Choledochal Cyst: A Prospective Randomized Controlled Trial
NCT07825935Children Following Robot-assisted Roux-en-Y Hepaticojejunostomy for Choledochal Cysts, Choledochal Cyst
Xueqiang Yan
Not applicable
80
Wuhan
2026-09-01
Not yet open
Effects of Energy Versus Mechanical Surgical Devices on Postoperative Cough
NCT07524712Postoperative Cough, Cough Hypersensitivity Syndrome
Tongji Hospital
Not applicable
248
Wuhan
2026-09-01
Not yet open
Effects of Different Acupuncture Techniques on the Success Rate in Patients With Recurrent Implantation Failure
NCT07669623Implantation Failure
Cui Hong Zheng
Not applicable
312
Wuhan
2026-09-01
Not yet open
Rituximab, Pirtobrutinib, Lisaftoclax and Liposomal Mitoxantrone for for Richter Syndrome Transformed From CLL
NCT07831395Richter Syndrome
DrugsLiposomal mitoxantrone·Lisaftoclax·Pirtobrutinib·Rituximab
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
23
Zhengzhou, Changsha, Nanchang, Guangzhou, Nanjing, Wuhan
2026-09-01
Not yet open
Early Diagnosis Model of Colorectal Adenoma Using Laboratory Examinations
NCT07793110Colorectal Adenoma, Polyp
Renmin Hospital of Wuhan University
Observational
400
Wuhan
2026-09-01
Not yet open
A Study of Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney Transplant
NCT07613359Antibody-Mediated Rejection (AMR)
DrugMezagitamab
Takeda
Phase 2
36
Beijing, Guangdong, Nanning, Wuhan, Xi'an, Jinan, Chengdu, Hangzhou
2026-09-01
Not yet open
A Study of ATG-201 in Adult Participants With Autoimmune Diseases
NCT07732309Systemic Lupus Erythematosus, Systemic Sclerosis (SSc), Sjogren's Disease, Autoimmune Diseases
Antengene Biologics Limited
Phase 1
149
Bengbu, Hefei, Beijing, Xiamen, Guangzhou, Luoyang, Zhengzhou, Wuhan
2026-09-01
Not yet open
A Study of SI-B036 in Patients With Locally Advanced or Metastatic Gynecological Tumors and Other Solid Tumors
NCT07778862Gynecological Tumors, Solid Tumors
DrugSI-B036
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
30
Wuhan
2026-09
Not yet open
A Clinical Trial of TQF3250 Capsules in Overweight/Obese Trial Participants With Poor Weight Control Through Simple Lifestyle Intervention
NCT07798284Overweight/Obesity
DrugTQF3250
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
80
Beijing, Guangzhou, Zhengzhou, Wuhan, Xianning, Jinan, Shanghai, Luzhou
2026-09
Not yet open
A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation
NCT07678593Advanced Solid Tumors Cancer, Pancreatic Ductal Adenocarcinoma, RAS Mutation
DrugsGFH276·Leucovorin·Fluorouracil·Cetuximab
Genfleet Therapeutics (Shanghai) Inc.
Phase 1/2
222
Beijing, Guangzhou, Harbin, Zhengzhou, Wuhan, Shenyang, Xi'an, Jinan
2026-09
Not yet open
AI-Assisted Chest CT Interpretation Across the Lung Cancer Care Continuum
NCT07829640Lung Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
15
Wuhan
2026-09
Not yet open
Phase 3 Study to Evaluate the Efficacy and Safety of Human Growth Hormone Injection (Sinotropin AQ) for the Treatment of Children With Idiopathic Short Stature
NCT07815626Idiopathic Short Stature (ISS)
DrugHuman Growth Hormone
Zhongshan Sansure Hygene Biomedicine Co., Ltd.
Phase 3
240
Hefei, Beijing, Xiamen, Guangzhou, Tangshan, Wuhan, Changsha, Nanjing
2026-09
Not yet open
Safety and Diagnostic Performance of 111In-TJD-31 SPECT Imaging in Patients With Solid Tumors
NCT07815951Solid Tumors, Carcinoma, Ovarian Neoplasms, Endometrial Neoplasms Malignant
Yong He
Phase 1
8
Wuhan
2026-09
Recruiting
A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
NCT07680764Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC)
DrugsImzokitug·Vedolizumab·Infliximab·Pumitamig
Bristol-Myers Squibb
Phase 2
160
Beijing, Fuzhou, Wuhan, Nanjing, Shanghai, Chengdu, Hangzhou
2026-08-31
Not yet open
Early EIT-Guided PEEP Titration on Pulmonary Physiology in Patients With Moderate-to-Severe ARDS Undergoing Prone Positioning (EIT-PEEP-PRONE)
NCT07793565Acute Respiratory Distress Syndrome (ARDS)
XIE MIN
Not applicable
40
Wuhan
2026-08-31
Recruiting
Phase II Study of Subretinal JWK001 for Neovascular Age-Related Macular Degeneration
NCT07776522Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
DrugAflibercept
West China Hospital
Phase 2
50
Beijing, Jilin City, Chongqing, Shantou, Zhejiang, Harbin, Zhengzhou, Wuhan
2026-08-31
Not yet open
A Phase 2 Study of ABSK043 Combined With Osimertinib
NCT07710612Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive
DrugsABSK043·Osimertinib
Abbisko Therapeutics Co, Ltd
Phase 2
72
Guangzhou, Harbin, Wuhan, Shenyang, Shanghai, Taiyuan, Hangzhou
2026-08-31
Recruiting
A Study of Chidamide Combined With Ivonescimab in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) With Acquired Resistance to Immunotherapy and High Yes-associated Protein (YAP) Expression
NCT07412262Non-Small Cell Lung Cancer
DrugsChidamide·Ivonescimab
Guangdong Association of Clinical Trials
Phase 2
32
Guangzhou, Wuhan
2026-08-28
Recruiting
A Clinical Trial Evaluating TQF3250 Capsules in Patients With Type 2 Diabetes Mellitus and Overweight/Obesity
NCT07747857Type 2 Diabetes Mellitus Combined With Overweight or Obesity
DrugTQF3250
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
72
Fuzhou, Guangzhou, Langfang, Luoyang, Wuhan, Yichang, Changsha, Nanjing
2026-08-25
Not yet open
Zuberitamab in the First Episode of Paediatric Nephrotic Syndrome
NCT07765914Nephrotic Syndrome
DrugZuberitamab
Children's Hospital of Fudan University
Phase 3
120
Shanghai, Changsha, Guiyang, Wuhan, Wuxi, Xiamen
2026-08-20
Not yet open
AI-Driven IOL Prediction Using SS-OCT Biometry
NCT07733154Cataract
The Hong Kong Polytechnic University
Observational
2,500
Wuhan
2026-08-20
Not yet open
Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease
NCT07384429Parkinson's Disease, Insomnia, Motor Disorder
DrugLemborexant
YangPan
Phase 4
44
Wuhan
2026-08-19
Recruiting
QLESP Block Versus PENG+LFCN Block for Total Hip Arthroplasty
NCT07771829Pain Management, Arthroplasty Total Hip Replacement
DrugRopivacaine
Huazhong University of Science and Technology
Not applicable
136
Wuhan
2026-08-19
Not yet open
Effects of Targeted Temporal Interference Stimulation of Cerebellar Nuclei on Tremor and Gait Disturbance in Parkinson's Disease Patients
NCT07384442Parkinson's Disease, Movement Disorders
YangPan
Not applicable
50
Wuhan
2026-08-19
Not yet open
Multi-Omics Prediction of Radiation Lung Injury in Immunotherapy-Treated Lung Cancer Patients
NCT07742800Lung Cancer (NSCLC), Lung Cancer (SCLC)
HAN GUANG
Observational
160
Wuhan
2026-08-15
Recruiting
Neoadjuvant Gemcitabine Plus Trastuzumab Rezetecan in HER2-positive UTUC
NCT07741448UTUC
DrugsTrastuzumab Rezetecan·Gemcitabine
Zhiquan Hu
Phase 2
54
Huanggang, Jingzhou, Shiyan, Wuhan, Xiangyang, Yichang
2026-08-15
Recruiting
A Study to Evaluate the Preliminary Efficacy and Safety of Terfenadine in Patients With Relapsing-Remitting Multiple Sclerosis
NCT07827716Relapsing Remitting Multiple Sclerosis
Chuan Qin
Phase 2
100
Wuhan
2026-08-15
Not yet open
Posterosuperior Bundle Pacing for Prevention of Atrial Fibrillation in Patients With Sinus Node Dysfunction
NCT07645066Pacing Therapy, Cardiac Pacing
Shanghai Tong Ren Hospital
Not applicable
300
Anqing, Tongling, Zunyi, Wuhan, Shanghai
2026-08-14
Recruiting
Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus
NCT06593392Pruritus, Chronic Kidney Diseases
Vifor Fresenius Medical Care Renal Pharma
Phase 2
18
Chengdu, Guangzhou, Hangzhou, Shanghai, Wuhan, Xi'an
2026-08-04
By invitation
An Investigation Into the Application of Preputial Grafts for the Reconstruction of Complex Ureteral Strictures
NCT07408050Ureteral Stenosis
Ruibao chen
Not applicable
50
Wuhan
2026-08-03
Recruiting
A Study of Econoglutide Injection in Obese Participants With Knee Osteoarthritis (KOA)
NCT07734311Knee Osteoarthritis, Obesity
DrugEcnoglutide
Hangzhou Sciwind Biosciences Co., Ltd.
Phase 3
360
Wuhan
2026-08-03
Not yet open
Phase โ…ข Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's Disease
NCT07741045Parkinson's Disease (PD), Parkinson Disease 6, Early-Onset
DrugTJ0113
Hangzhou PhecdaMed Co., Ltd.
Phase 3
300
Beijing, Chongqing, Guangzhou, Zhengzhou, Wuhan, Changsha, Suzhou, Shanghai
2026-08-03
Not yet open
RCT Study on the Effect of ETN on Live Birth Rate in DOR Patients Undergoing IVF-ET
NCT07769684Diminished Ovarian Reserve (DOR), Infertility (IVF Patients)
Huazhong University of Science and Technology
Not applicable
406
Shiyan, Wuhan, Xiangyang
2026-08-01
Not yet open
Tenecteplase or Reteplase as Bridging Thrombolysis Before Thrombectomy in Acute Ischemic Cerebrovascular Events
NCT07748039Acute Ischemic Stroke, Large Vessel Occlusion, Anterior Circulation Brain Infarction
DrugRhTNK-tPA
Yongjun Wang
Phase 3
1,440
Beijing, Wuhan, Xiangtan, Rizhao, Ya'an
2026-08-01
Not yet open
The Impact of Multimodal Brain Monitoring on Postoperative Outcomes in Elderly Patients Undergoing Major Abdominal Surgery
NCT07713355Anesthesia, General, Major Abdominal Surgeries
Xuanwu Hospital, Beijing
Not applicable
368
Beijing, Zhengzhou, Wuhan
2026-08-01
Not yet open
Efficacy and Safety of Lenalidomide in Patients With IgG4-Related Disease
NCT07719543Immunoglobulin G4-Related Disease
DrugLenalidomide
Chinese PLA General Hospital
Phase 3
146
Beijing, Sanya, Wuhan
2026-08-01
Not yet open
A Study Comparing BL-B01D1 in Combination With PD-1/VEGF Bispecific Antibody Versus Chemotherapy in Combination With PD-1/VEGF Bispecific Antibody in First-line Patients With Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer(PANKU-Lung05)
NCT07739199Squamous Non-small-cell Lung Cancer
DrugsIza-bren·Paclitaxel·Carboplatin
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2/3
200
Guangzhou, Wuhan
2026-08
Not yet open
A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Primary AL Amyloidosis
NCT07765524Primary Light Chain (AL) Amyloidosis
DrugFKC289
Shenzhen Fosun Kairos Biotechnology Co., Ltd.
Phase 1/2
32
Guangzhou, Nanning, Zhengzhou, Wuhan, Nanjing, Jinan, Shanghai, Chengdu
2026-08
Not yet open
Clinical Trial of TQB3126 for Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Breast Cancer Subjects
NCT07697443Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2
306
Guangzhou, Meizhou, Wuhan, Changsha, Chengdu, Tianjin
2026-08
Not yet open
A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Membranous Nephropathy
NCT07765537Primary Membranous Nephropathy
DrugFKC289
Shenzhen Fosun Kairos Biotechnology Co., Ltd.
Phase 1/2
55
Hefei, Beijing, Guangzhou, Shenzhen, Wuhan, Changsha, Nanjing, Chengdu
2026-08
Recruiting
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
NCT07521007Atherosclerosis, Coronary Artery Disease
Beijing Inno Medicine Co., Ltd.
Phase 2
456
Hefei, Beijing, Fuzhou, Lanzhou, Guangzhou, Harbin, Wuhan, Changsha
2026-07-31
Recruiting
IBI363 Combined With Bevacizumab for Advanced Colorectal Cancer
NCT07722494Colorectal Cancer
DrugsIBI363·Bevacizumab
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3
550
Wuhan, Hangzhou
2026-07-31
Not yet open
Clinical Application of FAP-Targeted Radionuclide Imaging in the Diagnosis and Staging of Malignant Solid Tumors
NCT07707999Malignant Neoplasm
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
20
Wuhan
2026-07-30
Not yet open
Clinical Evaluation of [68Ga]Ga-FFD PET Imaging in Healthy Volunteers and Patients With Solid Tumors
NCT07708103Solid Tumor Malignancies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
12
Wuhan
2026-07-30
Active, closed
Validation of a Deep Learning Tool for Opportunistic Osteoporosis Screening Using Routine Non-Contrast CT Scans
NCT07739628Osteoporosis
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
100
Wuhan
2026-07-28
Recruiting
Maintenance Immunotherapy With Deferred Salvage Radiotherapy After Response to Chemoimmunotherapy in Recurrent Nasopharyngeal Carcinoma
NCT07528183Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University
Phase 2
62
Fuzhou, Guangzhou, Nanning, Wuhan
2026-07-22
Not yet open
Efficacy and Safety of Retlirafusp Alfa Plus Bevacizumab and Chemotherapy With or Without Short-Course Radiotherapy in Patients With CRCLM
NCT07728019CRC (Colorectal Cancer)
DrugsRetlirafusp alfa·Folfox·Bevacizumab
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2
60
Wuhan
2026-07-22
Not yet open
QLESP Block for Pain Control in Robotic Partial Nephrectomy
NCT07704970Renal Cell Carcinoma (Kidney Cancer), Postoperative Pain, Nerve Block
DrugRopivacaine
Huazhong University of Science and Technology
Not applicable
120
Wuhan
2026-07-20
Recruiting
Study of JAB-23E73 in Combination With Chemotherapy in Participants With Metastatic PDAC Harboring KRAS Gene Alterations
NCT07640295Metastatic Pancreatic Ductal Adenocarcinoma
Jacobio Pharmaceuticals Co., Ltd.
Phase 1/2
80
Beijing, Hangzhou, Changsha, Harbin, Nanjing, Shanghai, Taiyuan, Wuhan
2026-07-16
Recruiting
Endovascular Treatment for Posterior Circulation Ischemic Stroke Post 1 Day ๏ผˆ24 Hours๏ผ‰
NCT07699029Posterior Circulation Ischemic Stroke
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
244
Wuhan
2026-07-16
Not yet open
SMP-656 for HER2-Positive Advanced Breast Cancer
NCT07726342HER2-positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast Cancer (LABC)
Chengdu SciMount Pharmatech Co., Ltd.
Phase 2
60
Hefei, Beijing, Guangzhou, Shijiazhuang, Zhengzhou, Wuhan, Changsha, Nanjing
2026-07-16
Recruiting
Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents
NCT07693426Adolescence Obesity
DrugEfsubaglutide Alfa
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
Phase 1
36
Beijing, Wuhan, Shenyang, Jinan
2026-07-16
Recruiting
A Study of HLX18 vs. OPDIVOยฎ in Multiple Resected Solid Tumors
NCT07518043Esophageal and/or Cardia Cancer, Melanoma, Urothelial Carcinoma (UC)
DrugOpdivo
Shanghai Henlius Biotech
Phase 1
174
Fuzhou, Hangzhou, Luoyang, Tianjin, Wenzhou, Wuhan, Xi'an
2026-07-15
Recruiting
Catheter-Oriented Unloading and Recovery With a Left Ventricular Assist Gear: Efficacy in Post Cardiotomy Cardiogenic Shock
NCT07560085Cardiogenic Shock
ForQaly Medical (Shanghai) Co., Ltd
Not applicable
60
Fuzhou, Wuhan
2026-07-14
Recruiting
Effects of Fospropofol Disodium TIVA and IVIH on Surgical Field Quality in Adult ESS
NCT07788157Fospropofol Disodium
DrugsFospropofol Disodium·Propofol
Tongji Hospital
Not applicable
144
Wuhan
2026-07-12
Recruiting
A Clinical Trial Evaluating the Tolerability, Safety, and Preliminary Efficacy of NRG-103 Injection in Patients With Recurrent or Progressive High-grade Glioma
NCT07710690HGG, High Grade Glioma (III or IV), High Grade Glioma
DrugNRG-103
Neuregen Therapeutics Co., Ltd.
Phase 1
24
Shanghai, Wuhan, Xi'an
2026-07-09
Active, closed
A Prospective Study of Cold Exposure in Patients With MASH
NCT07821749Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Renmin Hospital of Wuhan University
Not applicable
11
Wuhan
2026-07-08
Recruiting
Pucotenlimab Plus Becotatug Vedotin in Perioperative Treatment of Locally Advanced Resectable Head and Neck Squamous Cell Carcinoma
NCT07586124Head and Neck Squamous Cell Carcinoma
DrugsBecotatug Vedotin·Pucotenlimab
Lepu Biopharma Co., Ltd.
Phase 2
80
Beijing, Fuzhou, Guangzhou, Shantou, Nanning, Shijiazhuang, Wuhan, Changsha
2026-07-06
Not yet open
Universal STAR-T Cell Injection in Generalized Myasthenia Gravis
NCT07714798Generalized Myasthenia Gravis
Daishi Tian
Phase 1
10
Wuhan
2026-07-06
Recruiting
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
NCT07476287Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC ), Transformed Small Cell Lung Cancer, Lung Neoplasms
DrugPF-08634404
Pfizer
Phase 2
40
Beijing, Fuzhou, Zhengzhou, Wuhan, Nanchang, Shanghai
2026-07-02
Not yet open
Prospective Sample Collection Study for a Blood-Based cfDNA Methylation Assay for Ovarian Cancer Detection
NCT07593833Ovarian Neoplasms, Ovarian Cancer, Early Detection of Cancer
Tongji Hospital
Observational
1,000
Wuhan
2026-07-01
Not yet open
Study on the Impact of Decolonization Treatment of Pneumocystis Jirovecii on the Frequency of Acute Exacerbation in COPD
NCT07665359Chronic Obstructive Pulmonary Disease (COPD)
DrugsTMP/SMX·Trimethoprim-sulfamethoxazole
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
630
Guangzhou, Wuhan, Nanchang, Shanghai, Chengdu, Hangzhou, Huzhou, Jiaxing
2026-07-01
Not yet open
A Clinical Study of TQB2930 Injection and Chemotherapy With or Without Bevacizumab in the Treatment of Advanced Colorectal Cancer
NCT07653685Colorectal Cancer
DrugsTQB2930·Capecitabine·Oxaliplatin·Bevacizumab
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 1/2
71
Beijing, Lanzhou, Nanning, Zunyi, Harbin, Zhengzhou, Jingzhou, Wuhan
2026-07
Not yet open
Mindfulness Intervention on Minimally Invasive Vascular Surgery
NCT07463638Anxiety, Pain
Tongji Hospital
Not applicable
160
Wuhan
2026-07
Not yet open
Cardiopulmonary Exercise Testing-based High-intensity Interval Training For Improving Heart Failure With Preserved Ejection Fraction
NCT07693049HFpEF - Heart Failure With Preserved Ejection Fraction
Peking University Third Hospital
Not applicable
192
Beijing, Shanghai, Wuhan
2026-07
Not yet open
Intraarterial Therapies Plus Tislelizumab Plus Lenvatinib Versus Tislelizumab Plus Gemcitabine-Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma
NCT07691515Intrahepatic Cholangiocarcinoma (Icc)
DrugsLenvatinib·Tislelizumab·Gemcitabine·Cisplatin
Zhejiang Cancer Hospital
Phase 3
140
Guangzhou, Jiangmen, Wuhan, Changsha, Ganzhou, Nanchang, Qingdao, Chengdu
2026-07
Not yet open
Clinical Application Value of Deep Learning-Based "Opportunistic Screening" for Malignant Tumors on Routine Non-Contrast Chest-Abdomen-Pelvis CT
NCT07639567Tumor
Lian Yang
Observational
100,000
Wuhan
2026-07
Not yet open
Predictors of Epidural Depth in Percutaneous Nephrolithotomy and Model Development
NCT07697053Epidural Anesthesia, Percutaneous Nephrolithotomy (PCNL)
Tongji Hospital
Observational
3,278
Wuhan
2026-06-30
Not yet open
Effect of Acupuncture on the Success Rate in Patients With Recurrent Implantation Failure
NCT07486297Implantation Failure
Huazhong University of Science and Technology
Not applicable
208
Wuhan
2026-06-30
Not yet open
Neoadjuvant PD-1 Inhibitor Plus SOX Chemotherapy With or Without Short-Course Radiotherapy for Locally Advanced Upper Gastric or GEJ Adenocarcinoma
NCT07674342Locally Advanced Proximal Gastric or Gastroesophageal Junction Adenocarcinoma
Tongji Hospital
Not applicable
146
Wuhan
2026-06-30
Recruiting
Comparative Study of TIS Efficacy Across Different Targets
NCT07745673PARKINSON DIS
Zhongnan Hospital
Not applicable
18
Wuhan
2026-06-29
By invitation
Clinical Evaluation of [68Ga]Ga-ELI411 PET Imaging in Adult Patients With Solid Tumors
NCT07741006Malignant Solid Tumor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
18
Wuhan
2026-06-28
Recruiting
An Investigational Study of BG-75202 Alone and in Combination With Other Agents in Patients With Myeloid Malignancies
NCT07619287Myeloid Malignancy
DrugBG-75202
BeOne Medicines
Phase 1
118
Lanzhou, Guangzhou, Shijiazhuang, Zhengzhou, Wuhan, Suzhou, Nanchang, Tianjin
2026-06-23
Recruiting
Metabolic and Functional Study of ฮณฮด T Cells in Critically Ill Patients
NCT07680816Sepsis, Critical Illness, Immunosuppression, MODS
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
105
Wuhan
2026-06-21
By invitation
Predictive Efficacy of Fecal Calprotectin Assay by Magnetic Particle Chemiluminescence for Mucosal Healing in Moderate-to-Severe Ulcerative Colitis Patients Undergoing Initial Biologic Therapy๏ผˆPRECAL๏ผ‰
NCT07721441Ulcerative Colitis (UC)
Tang-Du Hospital
Observational
200
Beijing, Chongqing, Shenzhen, Wuhan, Nanjing, Shengyang, Qingdao, Xiโ€™an
2026-06-18
Recruiting
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
NCT07554339Non-small Cell Lung Cancer
DrugsCalderasib·Durvalumab
Merck Sharp & Dohme LLC
Phase 3
310
Hefei, Beijing, Xiamen, Nanning, Shijiazhuang, Wuhan, Changsha, Nanjing
2026-06-18
Recruiting
Clinical Effectiveness and Resource Use in End-Stage Renal Disease Patients: Remote Patient Monitoring Across Dialysis Modalities
NCT07781124End Stage Renal Disease (ESRD), Chronic Kidney Disease (CKD)
Vantive Health LLC
Observational
750
Beijing, Chongqing, Guangzhou, Shijiazhuang, Harbin, Zhengzhou, Wuhan, Changsha
2026-06-17
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
NCT07357727Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF)
DrugsPelabresib·Ruxolitinib
Novartis Pharmaceuticals
Phase 3
460
Hefei, Guangzhou, Wuhan, Nanjing, Nantong, Changchun, Jinan, Yantai
2026-06-16
Rows per page Showing 1–100 of 1343
1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-china/city/wuhan

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,343 of those studies with a site in Wuhan.

How many clinical trials are recruiting in Wuhan?

798 of the 1,343 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 226 have not yet opened recruitment, 281 are active but closed to new participants, and 38 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Wuhan), 1,343 studies
PhaseStudiesRecruitingShare
Phase 326110919.4%
Not applicable25013818.6%
Phase 222914117.1%
Observational21815516.2%
Phase 11439710.6%
Phase 1/2109688.1%
Phase 452303.9%
Phase EARLY_PHASE150353.7%
Phase 2/331252.3%

Most active sponsors

Lead sponsors with the most studies (Wuhan)
Lead sponsorStudiesRecruiting
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology165106
Tongji Hospital13989
Huazhong University of Science and Technology4523
Novartis Pharmaceuticals3315
AbbVie316
Zhongnan Hospital3120
Merck Sharp & Dohme LLC2715
Pfizer2612
Renmin Hospital of Wuhan University2113
AstraZeneca1710
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.